Chicago, Feb. 03, 2026 (GLOBE NEWSWIRE) -- The global in-vitro toxicology testing market was valued at 26.00 billion in 2024 and is expected to reach US$ 57.55 billion by 2033, growing at a CAGR of ...
The global In-vitro Diagnostics Market is projected to grow from US$ 112.04 billion in 2025 to US$ 218.73 billion by 2034, registering a CAGR of 7.8% during 2026 to 2034, according to a new market ...
In the worst-case scenario, getting chemicals in your eyes can lead to blindness. Until now, the eye irritancy potential of chemical substances has had to be assessed using the Draize test on live ...
The World Health Organization (WHO) has listed the first mpox in vitro diagnostic (IVD) under its Emergency Use Listing (EUL) procedure, an important step in improving global access to mpox testing.
Scientists engineered an HVEM-derived peptide that blocked about sixty percent of HSV-1 infection in cell tests without ...
In a recent study posted to the bioRxiv* preprint server, researchers developed a novel in vitro model that expresses the angiotensin-converting enzyme 2 (ACE-2) receptor from seven bar species in a ...
As the pandemic escalated, in August 2020, the Trump administration Health and Human Services (HHS) directed the Food and Drug Administration (FDA) to stop requesting premarket approval for clinical ...
On October 3, 2024, the WHO approved the first mpox in vitro diagnostic through its Emergency Use Listing procedure. According to the organization's press release, this approval marks a move toward ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results